Aurobindo Receives Approval for Sumatriptan Naproxen Sodium Tabs
East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Sumatriptan and Naproxen Sodium Tablets, 85 mg/500 mg. Aurobindo’s Sumatriptan and Naproxen Sodium Tablets are an AB-rated generic equivalent to the reference listed drug Treximet®. Sumatriptan and Naproxen Sodium tablets […]
Aurobindo Receives Approval for Sumatriptan Naproxen Sodium Tabs Read More »